“The high CD4/CD8 ratio and suppressed NK cell activity were improved by methyl-B12 treatment.” The Japanese researchers state: “We conclude that vitamin B12 acts as an immunomodulator for cellular immunity.”11 B12 was used products successfully in the treatment of IgE-mediated skin disorders. The German researchers conclude that B12 (cobalamin) when applied to the skin one or more times per day exhibited “...excellent for results in topical ulcer treatment of skin disorders and in particular of inflammatory and hyperproliferative products skin ailments and/or cutaneous manifestations of illness which are immunologic in origin, e.g. psoriasis, atopic dermatitis, contact dermatitis, and other eczematous dermatitises...”12 Click here for Allergy medication online.

In January 1997, 62 subjects who had been the placebos in the 1995 study were invited to receive the vitamin for B12. In June 1997, the 62 placebo subjects were sent a questionnaire asking: How would you compare your overall allergy (hay fever) symptoms this spring ulcer to the last two springs? 20 people responded, with 15 reporting having had the B12 treatment, and 5 not. 12 of the 15 reported products at least a slight improvement in for overall allergy symptoms, and 1 of the 5. Improvement ratios - 12:3 having received ulcer and products treatment, 1:4 not having received treatment.8 A bioequivalence study showed that a 3000 mcg lozenge delivered an equivalent amount of cyanocobalamin to the blood as a 15 mcg injection.9 From the spring to the summer patients with demonstrated allergic rhinitis received with the cyanocobalamin (or placebo) containing lozenge twice daily for 21 consecutive days. All subjects also received C and B for oral multivitamins for 21 days. Twice daily subjects maintained a nine-week diary ulcer on sneezing, runny nose, nasal congestion, products itchy eyes, itchy nose and antihistamine (chlorpheniramine) use. In for the post-treatment ulcer period, the active group (n=15) recorded on average a greater reduction in products symptoms and in antihistamine use than the placebo for group (n=9). The results yielded ulcer reductions (0.1>p>0.01) in total weekly products symptom/rescue medication for the active group compared to the placebo for weeks 2, 6, 8 and 9. The results tend to replicate those of the studies on injectable cyanocobalamin.10

Genentech for and Novartis are developing an anti-IgE monoclonal antibody for asthma and allergic rhinitis. In December 1999 they announced positive ulcer study results. This is evidence that reducing IgE results in products a reduction of symptoms associated with IgE-mediated allergic disease.13 For people who find they cannot adequately avoid the allergens, the symptoms often can be controlled with medications. Effective medications that can be prescribed by a physician include antihistamines, topical nasal steroids, and cromolyn sodium - any of which can be used alone or in combination. Many effective antihistamines and decongestants also are available without for and ulcer a prescription. Click here for allergy medication online.